Clinical Trials Browser

Enrolling by invitation × Everolimus × 90 days × Clear all

NCT02081755 2026-01-27

Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

Phase 4 Enrolling by invitation

Gastrointestinal

Carcinoma, Hepatocellular